American Type Culture Collection (ATCC) Logo American Type Culture Collection (ATCC) Logo 0
  • Quick Order
  • Careers
  • Support

Episode 6: The Future of Extracellular Vesicle Research in Therapeutic and Diagnostic Development

Featuring Drs Fatah Kashanchi and Heather Branscome

 

Listen on Apple Podcasts button Listen on YoutUbe Music button Listen on Spotify button Listen on Pandora button

Guests:

Fatah Kashanchi, headshot.

Fatah Kashanchi, PhD

Professor, George Mason University

Dr. Kashanchi received his PhD in 1990 under the supervision of Dr. Charles Wood who also worked with the Nobel Laurite, Dr. Susumu Tonegawa at MIT. He then moved to National Cancer Institute at NIH’s intramural program and continued his work on RNA viral infections with the late John Brady on HIV and HTLV transcription and chromatin complexes.  He is currently a Tenured Faculty in the department of Systems Biology at the Prince William Campus of George Mason University.  He has obtained independent funding of more than $28.9 M in funding (NIH, DOD, DOE, and Keck) since his departure from NIH in 2000. He has published more than 270 peer-reviewed manuscripts (h index = 76) and served as an editorial board and reviewer for number of journals including Cell, Molecular Cell, Nature, Nature Medicine, Science Translational Medicine, Retrovirology, JBC, J. Virol, Virology, NAR, and 4 PLoS journals. He is a regular NIH study section member and has served on 163 panels and chaired 21 since 2000. 

Heather Branscome headshot

Heather Branscome, MS, PhD

Senior Scientist, ATCC

Dr. Heather Branscome is a Senior Scientist with ATCC. Throughout her 17-year career she has gained broad experience working in both academic and industry settings. She has extensive experience in cell and molecular biology and completed her graduate training in Biosciences from George Mason University. While at ATCC she has held positions in manufacturing, quality control, and technology transfer to support the production and qualification of cell lines and other critical biological reagents to support the scientific community. In her current role she manages a team of biologists to support the CDC’s International Reagent Resources (IRR) program, as well as other government contracts. Since 2018, she has played a key role in establishing and maintaining ATCC’s extracellular vesicle (EV) portfolio. In this role she was responsible for developing and validating large-scale EV manufacturing protocols and performing various EV biochemical and functional assays. Her current research is focused on advanced methods for EV purification, characterization of novel EV subtypes, and mechanistic studies of stem cell-derived EVs in different models of cellular repair. She currently serves as director and instructor for two local Bio-Trac® biotechnology training programs and maintains an active affiliation with George Mason University.

Show Notes:

Extracellular vesicles such as exosomes are an emerging area of interest for scientists in both the academic and biopharma communities. In this episode, Drs. Kashanchi and Branscome discuss the future of EV research. A major hurdle to overcome will be purification, because the function of EVs comes from the cells from which they were derived, their size, and their cargo. Additionally, they discuss the synergistic relationship between ATCC Laboratory Operations and the George Mason University (GMU) Laboratory of Molecular Virology and how it could be a model for other collaborations between industry and academia.

Host:

David Yarmosh, headshot.

David Yarmosh, MS

Lead Bioinformatician, ATCC

David Yarmosh is a lead bioinformatician in ATCC’s Sequencing and Bioinformatics Center. He’s a graduate of New York University’s Tandon School of Engineering. He has been working in large data aggregation and analysis since 2013 and microbial genomics with a focus on biosurveillance R&D efforts since 2016. David has led international training exercises in Peru and Senegal, sharing metagenomic analytical capabilities. His interests include genomics database construction, metadata collection, drug resistance mechanisms, bioinformatics standards, and machine learning. Since joining ATCC in 2020, David has worked extensively in SARS-CoV-2 classification, epidemiology, and genomics evaluation, including enhanced and uniform variant reporting. He has contributed more broadly to genomics reporting and analytical standardization and he has helped develop the podcast Behind the Biology, which he now hosts.

Large green sphere releasing several small green exosome spheres. Illustration.

Exosomes

Standards for diagnostic tests, disease markers, and functional studies

Learn more